About
Xenios AG develops and provides extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) medical technologies, including a multifunctional console for combined heart and lung support used in the treatment of critical cardiac and pulmonary failure patients.
Explore Xenios AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.